Nurse phone calls may ease chemo side effects and anxiety
NCT ID NCT01977053
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether two nurse phone calls during the first three cycles of chemotherapy could improve the emotional state and quality of life of patients with breast, colon, or rectal cancer. 274 patients were randomly assigned to receive either standard care or standard care plus the phone calls. The goal was to see if the calls reduced anxiety, depression, and other mood problems, and helped manage side effects.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- telephone-based monitoring
- What this could lead to
- If it works, this could show that simple phone calls can reduce anxiety and improve quality of life for people undergoing chemotherapy.
- What could go wrong
- This is a completed study, but the intervention is very basic and may not have a strong effect. Results may not apply to all cancer types or treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
274 people
The number who actually took part.
- Start date
-
Sep 2013
- Finished
-
Dec 2018
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient older than 18. * Patient surgically-treated or no for non inflammatory breast cancer or for colon cancer or rectal cancer. * Patient to be treated by neo-adjuvant or adjuvant chemotherapy by 5-fluorouracil, epirubicin and cyclophosphamide (FEC)-docetaxel, docetaxel-cyclophosphamide, 5-fluorouracil/leucovorin with oxaliplatin(FOLFOX) or XELOX. A treatment with trastuzumab is allowed in association. * Patient never treated by chemotherapy. * Patient with Performance Status under or equal to 2. * Patient with adequate hematopoietic, hepatic and cardiac functions according to the investigator. * Patient having read with the information note and having signed the informed consent. * Patient beneficiating from French health insurance cover. Exclusion Criteria: * Patient with psychological state, geographical remote or social problems that contraindicated the participation into the study according to the investigator. * Patient that must be treated for a metastatic disease. * Patient not able to attend all study visits. * Patient not understanding French. * Patient who don't have a phone. * Vulnerable patient: pregnant or breast-feeding women, person deprived of freedom by an administrative or judicial decision, person older than 18 being the object of a legal protection measure or outside state to express their consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non-metastatic patients with breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Antoine Lacassagne
Nice, Cedex 2, 06189, France
-
Polyclinique St Jean
Cagnes-sur-Mer, 06800, France